Coverage
Filings
| Filing | Date |
|---|---|
| Publication of Offering Circular | 7 Jul 2025 |
| Director/PDMR Shareholding | 9 Jun 2025 |
| Director/PDMR Shareholding | 5 Jun 2025 |
| Director/PDMR Shareholding | 3 Jun 2025 |
| Fitch upgrades Hikma to ‘BBB’ | 29 May 2025 |
| Director/PDMR Shareholding | 20 May 2025 |
| Medium-term Group guidance ahead of US site visit | 15 May 2025 |
| Settlement agreement for Xyrem® US lawsuits | 8 May 2025 |
Hikma Pharmaceuticals lowered its medium-term profit growth forecast, citing delays at a new manufacturing facility in the U.S.
| 8 May 2025 |
| Director/PDMR Shareholding | 8 May 2025 |
| Director/PDMR Shareholding | 30 Apr 2025 |
| Trading Statement | 24 Apr 2025 |